Choksi Laborator

Market Cap: Micro Cap
Industry: Hospital & Healthcare Services
ISIN: INE493D01013
NSEID:
BSEID: 526546

INR

98.45

-5.15 (-4.97%)

BSENSE

Apr 11, 12:39 PM

BSE+NSE Vol: 5.73 k

{
  "main_header": {
    "sid": 525405,
    "name": "Choksi Laborator",
    "stock_name": "Choksi Laborator",
    "full_name": "Choksi Laboratories Ltd",
    "name_url": "stocks-analysis/choksi-laborator",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "98.45",
    "chg": -5.15,
    "chgp": "-4.97%",
    "dir": -1,
    "prev_price": "103.60",
    "mcapval": "72.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526546,
    "symbol": "",
    "ind_name": "Hospital & Healthcare Services",
    "ind_code": 94,
    "isin": "INE493D01013",
    "curr_date": "Apr 11, 12:39 PM",
    "curr_time": "23:54 PM",
    "bse_nse_vol": "5.73 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/choksi-laborator-525405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Choksi Laboratories Faces Mixed Indicators Amidst Financial Performance Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-stock-downgraded-to-sell-amid-declining-profits-and-high-debt-levels-1598181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ChoksiLaborator_mojoScore_794623.png",
        "date": "2025-03-26 08:01:18",
        "description": "Choksi Laboratories, a microcap in the Hospital & Healthcare Services sector, has experienced a recent evaluation adjustment amid mixed technical indicators. The company's financial performance has been stable, with modest annual growth in net sales, while its debt servicing capability appears limited. Despite challenges, it has outperformed broader market indices."
      },
      {
        "title": "Choksi Laboratories Faces Intense Selling Pressure Amidst Ongoing Stock Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-ltd-faces-significant-selling-pressure-declines-4-40-amid-ongoing-losses-1502291",
        "imagepath": "",
        "date": "2025-03-20 11:45:07",
        "description": "Choksi Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline of 4.40% in its stock price, contrasting sharply with the Sensex, which has gained 0.61% on the same day. This marks a continuation of a downward trend, as Choksi Laboratories has recorded losses for three consecutive days.\n\nOver the past week, the stock has decreased by 2.08%, while the Sensex has risen by 2.82%. In the last month, Choksi Laboratories has seen a decline of 3.42%, compared to a modest increase of 0.23% in the Sensex. Despite a strong performance over the longer term, including a remarkable 186.68% increase over the past year, the recent selling activity raises questions about the stock's immediate outlook.\n\nThe stock opened down 3.61% today and reached an intraday low of Rs 127.05, reflecting a significant underperformance against..."
      },
      {
        "title": "Choksi Laboratories Faces Mixed Financial Performance Amid Valuation Adjustments and Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-receives-hold-rating-amid-flat-financial-performance-and-high-debt-levels-1270058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ChoksiLaborator_mojoScore_636977.png",
        "date": "2025-03-11 08:01:59",
        "description": "Choksi Laboratories, a microcap in the Hospital & Healthcare Services sector, recently experienced an evaluation adjustment. The company reported flat financial performance for the quarter ending December 2024, with a significant annual return, despite a decline in profits and challenges related to long-term fundamental strength and debt servicing capacity."
      },
      {
        "title": "Choksi Laboratories Achieves 116.66% Annual Gain Amid Strong Buying Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-ltd-surges-1-97-today-achieves-77-21-growth-over-last-three-months-1232091",
        "imagepath": "",
        "date": "2025-03-07 10:30:51",
        "description": "Choksi Laboratories Ltd, a microcap player in the Hospital & Healthcare Services sector, is witnessing significant buying activity, marking a notable performance against the broader market. Today, the stock has gained 1.97%, outperforming the Sensex, which has only seen a 0.15% increase. Over the past week, Choksi Laboratories has recorded a total gain of 1.89%, compared to the Sensex's 1.72%.\n\nThe stock has been on an upward trajectory for the last two days, accumulating a total return of 3.98% during this period. Despite a decline of 8.76% over the past month, Choksi Laboratories has shown remarkable resilience with a staggering 116.66% increase over the past year, significantly outpacing the Sensex's modest 0.45% gain.\n\nToday, the stock opened at 121.35 and has maintained this price level throughout the trading session. It is currently trading above its 5-day, 50-day, 100-day, and 200-day moving averages..."
      },
      {
        "title": "Choksi Laboratories Ltd Sees Notable Buying Activity Amidst Market Stability",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-ltd-surges-1-97-today-achieves-120-13-annual-price-increase-amid-market-trends-3-1216936",
        "imagepath": "",
        "date": "2025-03-06 10:35:12",
        "description": "Choksi Laboratories Ltd is witnessing significant buying activity today, with the stock rising by 1.97%. This performance notably outpaces the Sensex, which has shown a minimal increase of just 0.01%. After experiencing two consecutive days of decline, the stock's upward movement indicates a potential trend reversal.\n\nOver the past week, Choksi Laboratories has seen a decline of 2.06%, while the Sensex fell by 1.17%. However, the stock's longer-term performance remains impressive, with a remarkable 120.13% increase over the past year compared to the Sensex's slight decline of 0.47%. In the last three months, Choksi Laboratories has surged by 73.77%, contrasting sharply with the Sensex's drop of 9.75%.\n\nThe stock opened at 119 today and has maintained this price level throughout the trading session, indicating stability amidst the buying pressure. Additionally, it is trading above its 50-day, 100-day, and 20..."
      },
      {
        "title": "Choksi Laboratories Faces Financial Challenges Amidst Modest Growth and Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-stock-downgraded-to-sell-amid-flat-financial-performance-and-debt-concerns-1212827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ChoksiLaborator_mojoScore_595406.png",
        "date": "2025-03-06 08:01:01",
        "description": "Choksi Laboratories, a microcap in the Hospital & Healthcare Services sector, has recently experienced a score adjustment reflecting its financial performance and underlying trends. The company reported flat quarterly results, modest sales growth, and a high Debt to EBITDA ratio, indicating challenges in expansion and debt servicing."
      },
      {
        "title": "Choksi Laboratories Ltd Sees Strong Buying Amid Long-Term Gains and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-ltd-rises-1-98-today-up-112-09-over-past-year-despite-recent-decline-1204800",
        "imagepath": "",
        "date": "2025-03-05 12:25:07",
        "description": "Choksi Laboratories Ltd, a microcap player in the Hospital & Healthcare Services sector, is currently witnessing strong buying activity. Today, the stock has gained 1.98%, outperforming the Sensex, which rose by 1.12%. However, it has faced challenges over the past week, with a decline of 2.18%, while the Sensex fell by 1.06%. \n\nIn the short term, Choksi Laboratories has experienced consecutive losses, with a drop of 3.3% over the last two days. Despite this recent downturn, the stock has shown remarkable long-term performance, boasting a staggering 112.09% increase over the past year, compared to the Sensex's modest gain of 0.18%. \n\nToday's trading saw the stock open with a gap up and reach an intraday high, although it has been trading within a narrow range of Rs 0.7. The stock's moving averages indicate it is above the 50-day, 100-day, and 200-day averages, yet below the 5-day and 20-day averages. This m..."
      },
      {
        "title": "Choksi Laboratories Faces Intense Selling Pressure Amid Consecutive Losses and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-faces-selling-pressure-with-10-71-monthly-loss-amid-ongoing-declines-1180320",
        "imagepath": "",
        "date": "2025-03-04 10:52:46",
        "description": "Choksi Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend is underscored by consecutive days of losses, as the stock has declined by 0.77% over the past week and 10.71% over the last month. In contrast, the broader market, represented by the Sensex, has also experienced declines, but Choksi Laboratories' performance has been notably weaker in the short term.\n\nDespite its recent struggles, Choksi Laboratories has demonstrated strong long-term performance, with a remarkable 109.25% increase over the past year and a staggering 355.56% rise over the last three years. However, the current selling pressure may be attributed to various factors, including market sentiment and sector-specific challenges within the Hospital & Healthcare Services industry.\n\nIn terms of price summary, Choksi Laboratories opened at 123 and has maintained this level th..."
      },
      {
        "title": "Choksi Laboratories Reports Steady Financial Performance Amid Evaluation Score Shift in February 2025",
        "link": "https://www.marketsmojo.com/news/result-analysis/choksi-laboratories-reports-flat-financial-performance-for-december-2024-1014155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/ChoksiLaborator_quaterlyResult_450455.png",
        "date": "2025-02-14 18:50:20",
        "description": "Choksi Laboratories has announced its financial results for the quarter ending December 2024, revealing a steady performance with no significant fluctuations in key metrics. The company's stock evaluation has notably shifted, prompting stakeholders to monitor future developments in the healthcare sector closely."
      }
    ],
    "total": 57,
    "sid": "525405",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/choksi-laboratories-525405"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Pursuant to Regulation 74(5) of SEBI (DP) Regulation 2018 attached herewith the certificate issued by RTA of the company",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Intimation for closure of trading window w.e.f. 01.04.2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Feb-2025",
      "details": "Extract of Unaudited Financial Results for the quarter and nine months ended 31st December 2024 which has been published in the newspaper",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Choksi Laboratories Faces Mixed Indicators Amidst Financial Performance Challenges

2025-03-26 08:01:18

Choksi Laboratories, a microcap in the Hospital & Healthcare Services sector, has experienced a recent evaluation adjustment amid mixed technical indicators. The company's financial performance has been stable, with modest annual growth in net sales, while its debt servicing capability appears limited. Despite challenges, it has outperformed broader market indices.

Choksi Laboratories Faces Intense Selling Pressure Amidst Ongoing Stock Decline

2025-03-20 11:45:07

Choksi Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline of 4.40% in its stock price, contrasting sharply with the Sensex, which has gained 0.61% on the same day. This marks a continuation of a downward trend, as Choksi Laboratories has recorded losses for three consecutive days. Over the past week, the stock has decreased by 2.08%, while the Sensex has risen by 2.82%. In the last month, Choksi Laboratories has seen a decline of 3.42%, compared to a modest increase of 0.23% in the Sensex. Despite a strong performance over the longer term, including a remarkable 186.68% increase over the past year, the recent selling activity raises questions about the stock's immediate outlook. The stock opened down 3.61% today and reached an intraday low of Rs 127.05, reflecting a significant underperformance against...

Choksi Laboratories Faces Mixed Financial Performance Amid Valuation Adjustments and Debt Concerns

2025-03-11 08:01:59

Choksi Laboratories, a microcap in the Hospital & Healthcare Services sector, recently experienced an evaluation adjustment. The company reported flat financial performance for the quarter ending December 2024, with a significant annual return, despite a decline in profits and challenges related to long-term fundamental strength and debt servicing capacity.

Choksi Laboratories Achieves 116.66% Annual Gain Amid Strong Buying Activity

2025-03-07 10:30:51

Choksi Laboratories Ltd, a microcap player in the Hospital & Healthcare Services sector, is witnessing significant buying activity, marking a notable performance against the broader market. Today, the stock has gained 1.97%, outperforming the Sensex, which has only seen a 0.15% increase. Over the past week, Choksi Laboratories has recorded a total gain of 1.89%, compared to the Sensex's 1.72%. The stock has been on an upward trajectory for the last two days, accumulating a total return of 3.98% during this period. Despite a decline of 8.76% over the past month, Choksi Laboratories has shown remarkable resilience with a staggering 116.66% increase over the past year, significantly outpacing the Sensex's modest 0.45% gain. Today, the stock opened at 121.35 and has maintained this price level throughout the trading session. It is currently trading above its 5-day, 50-day, 100-day, and 200-day moving averages...

Choksi Laboratories Ltd Sees Notable Buying Activity Amidst Market Stability

2025-03-06 10:35:12

Choksi Laboratories Ltd is witnessing significant buying activity today, with the stock rising by 1.97%. This performance notably outpaces the Sensex, which has shown a minimal increase of just 0.01%. After experiencing two consecutive days of decline, the stock's upward movement indicates a potential trend reversal. Over the past week, Choksi Laboratories has seen a decline of 2.06%, while the Sensex fell by 1.17%. However, the stock's longer-term performance remains impressive, with a remarkable 120.13% increase over the past year compared to the Sensex's slight decline of 0.47%. In the last three months, Choksi Laboratories has surged by 73.77%, contrasting sharply with the Sensex's drop of 9.75%. The stock opened at 119 today and has maintained this price level throughout the trading session, indicating stability amidst the buying pressure. Additionally, it is trading above its 50-day, 100-day, and 20...

Choksi Laboratories Faces Financial Challenges Amidst Modest Growth and Debt Concerns

2025-03-06 08:01:01

Choksi Laboratories, a microcap in the Hospital & Healthcare Services sector, has recently experienced a score adjustment reflecting its financial performance and underlying trends. The company reported flat quarterly results, modest sales growth, and a high Debt to EBITDA ratio, indicating challenges in expansion and debt servicing.

Choksi Laboratories Ltd Sees Strong Buying Amid Long-Term Gains and Market Dynamics

2025-03-05 12:25:07

Choksi Laboratories Ltd, a microcap player in the Hospital & Healthcare Services sector, is currently witnessing strong buying activity. Today, the stock has gained 1.98%, outperforming the Sensex, which rose by 1.12%. However, it has faced challenges over the past week, with a decline of 2.18%, while the Sensex fell by 1.06%. In the short term, Choksi Laboratories has experienced consecutive losses, with a drop of 3.3% over the last two days. Despite this recent downturn, the stock has shown remarkable long-term performance, boasting a staggering 112.09% increase over the past year, compared to the Sensex's modest gain of 0.18%. Today's trading saw the stock open with a gap up and reach an intraday high, although it has been trading within a narrow range of Rs 0.7. The stock's moving averages indicate it is above the 50-day, 100-day, and 200-day averages, yet below the 5-day and 20-day averages. This m...

Choksi Laboratories Faces Intense Selling Pressure Amid Consecutive Losses and Market Challenges

2025-03-04 10:52:46

Choksi Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend is underscored by consecutive days of losses, as the stock has declined by 0.77% over the past week and 10.71% over the last month. In contrast, the broader market, represented by the Sensex, has also experienced declines, but Choksi Laboratories' performance has been notably weaker in the short term. Despite its recent struggles, Choksi Laboratories has demonstrated strong long-term performance, with a remarkable 109.25% increase over the past year and a staggering 355.56% rise over the last three years. However, the current selling pressure may be attributed to various factors, including market sentiment and sector-specific challenges within the Hospital & Healthcare Services industry. In terms of price summary, Choksi Laboratories opened at 123 and has maintained this level th...

Choksi Laboratories Reports Steady Financial Performance Amid Evaluation Score Shift in February 2025

2025-02-14 18:50:20

Choksi Laboratories has announced its financial results for the quarter ending December 2024, revealing a steady performance with no significant fluctuations in key metrics. The company's stock evaluation has notably shifted, prompting stakeholders to monitor future developments in the healthcare sector closely.